Navigating this blog

I will post an evidence-based review on a off-label drug of interest from time to time (one a month on average, as I can manage).

The post will be organzed with an overview, the evidence [test-tube -> animal -> human (cases and trials)], and a “my take” or “future directions” section giving my personal opinion on how the drug can be optimally integrated into a cocktailed approach for cancer therapy.

Those interested in this general topic should browse under the TOPIC page and see what has been posted and what topics I plan to write about.

Those interested in specific cancer applications can use the “search” function, or look under tags or keywords or categories (e.g. breast cancer).  Each drug can be looked under categories of individual cancers:

Breast, Lung (NSCLC and SCL), colorectal, gastric, pancreas (under hepatobiliary), liver (under hepatobiliary), head and beck, melanoma, uterine, ovary, glioblastoma (glioma and other CNS tumors), other.

Or, they can be searched under individual mechanisms of action:

immune, apoptosis, angiogenesis,

Or, under cancer applications:

prevention, treatment, enhance chemo or radiotherapy, side-effect moderation, quality of life improvement

Feel free to contact me if you are interested in me looking into or reviewing or posting a topic drug …